Therese K L, Gayathri R, Dhanurekha L, Sridhar R, Meenakshi N, Madhavan H N
Larsen & Toubro Microbiology Research Centre, Vision Research Foundation, Chennai, Tamil Nadu, India.
Indian J Med Microbiol. 2013 Oct-Dec;31(4):366-9. doi: 10.4103/0255-0857.118887.
Early diagnosis of tuberculosis is critical for its effective management and prevention. Several gene amplification methods are used in the detection of tubercle bacilli from clinical specimens. MPB64 gene and IS6110 region have been identified as potential gene targets for the specific detection of Mycobacterium tuberculosis from direct clinical specimens.
The present study was conducted to evaluate the diagnostic utility of simultaneous application of two nested polymerase chain reaction (nPCRs) targeting MPB64 and IS6110 region for the detection of M. tuberculosis genome.
A total of 100 and 354 clinical specimens from the control group and clinically suspected tuberculosis patients, respectively, were included in the study. nPCRs targeting MPB64 and IS6110 region were performed.
All of the 100 clinical specimens from the control group were negative for both nPCRs. Out of the 354 clinical specimens, 339 were positive for both culture and nPCRs, 10 and 5 were positive for culture, and nPCR targeting IS6110 and MPB64 regions, respectively. To conclude, nPCRs targeting MPB64 and IS6110 region are reliable and specific targets when applied simultaneously on clinical specimens to attain 100% sensitivity for the detection of M. tuberculosis genome.
结核病的早期诊断对其有效管理和预防至关重要。几种基因扩增方法用于从临床标本中检测结核杆菌。MPB64基因和IS6110区域已被确定为从直接临床标本中特异性检测结核分枝杆菌的潜在基因靶点。
本研究旨在评估同时应用针对MPB64和IS6110区域的两种巢式聚合酶链反应(nPCR)检测结核分枝杆菌基因组的诊断效用。
本研究共纳入了分别来自对照组和临床疑似结核病患者的100份和354份临床标本。进行了针对MPB64和IS6110区域的nPCR。
对照组的100份临床标本两种nPCR检测均为阴性。在354份临床标本中,339份培养和nPCR检测均为阳性,10份和5份分别培养阳性,nPCR针对IS6110和MPB64区域检测阳性。总之,同时应用针对MPB64和IS6110区域的nPCR检测临床标本时,是可靠且特异的靶点,对结核分枝杆菌基因组检测可达到100%的灵敏度。